Botox Market Introduction & Overview

Botox refers to Botulinum Toxins, a protein which is produced by Gram-positive, spore forming bacterium Clostridium Botulinum. Botulinum toxin is a potent neurotoxin protein that inhibits signal conduction to the neuromuscular endplate. The toxin acts directly on the neuromuscular endplate and other cholinergic synapses where it inhibits the release of neurotransmitter acetylcholine, leading to muscular paralysis of the affected fiber and loss of target organ function. Limited and diluted amounts of botulinum toxin is used for treating several therapeutic indications such as cervical dystonia, lazy eye,  muscle contractures, hyperhidrosis, chronic migraine and bladder dysfunction among others. There are seven serologically distinct types of botulinum toxin such as A, B, C1, D, E, F, and G. Botulinum toxin types A and B are commonly used in medical preparations for treatment of muscle spasms.

The global botox market is driven by increasing focus on innovation & expansion of product portfolio by launch of new and efficient aesthetic & therapeutic substances. Moreover, increasing preference of non-surgical cosmetic procedures in contributing to the augmented application of botox in cosmetic procedures. However, the potential health risk associated with botulinum toxin is hampering the market growth.

The global botox market is segmented by type, application, end user and region.

Botox Market by Type

On the basis of type, the botox market is segmented into botulinum Toxin Type A and botulinum Toxin Type B. The botulinum Toxin Type A segment is estimated to account for the largest share in the global botox market. The large share of this segment can be attributed to the wide scale application of botulinum Toxin Type A owing to its high potency for treatment of focal dystonias, hemifacial spasm, and spasticity.

Botox Market by Application

On the basis of application, the market can be segmented into aesthetics and therapeutics. In terms of market share, the segment of therapeutics is estimated to account for the largest market share, owing to increasing administration of botulinum toxin for wide range of medical conditions such as bladder dysfunction, migraine and muscle contractures.

Botox Market by End User

Similarly, in terms of end user, the botox market can be segmented into specialty & dermatology clinics and hospital & clinics. The segment of hospital & clinics is estimated to grow at a robust CAGR during the forecast period owing to the increasing application of botulinum toxin for several medical conditions in addition to its general application in dermatological procedures. Moreover, increasing number of technologically advanced and specialized clinics is attributed to the growth of this segment.

Botox Market by Region

The global botox market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of botox market, followed by Europe and Asia Pacific. North America dominates the global botox market owing to factors such increasing number of aesthetic procedures, high adoption rate of novel techniques and extensive research & development by key players in this region.  However, Asia Pacific is expected to witness the highest CAGR, with the growth of the market centered at China, Korea and Japan. Factors such as rising interest in aesthetic procedures and increased consumer awareness is attributed for the growth of botox market in this region.

Botox Market Prominent Players

Some prominent players in the botox market include Allergan, Ipsen Group, Medytox, Merz Pharma, HUGEL, Inc, US WorldMeds, LLC, Galderma Laboratories, L.P., Revance Therapeutics, Inc, Eisai Co., Ltd. and DAEWOONG CO.LTD among others.